WE ARE GOING HYBRID!
Platinum Partner
Pharmacor is one of the leading generic pharmaceutical companies in Australia supplying high-quality prescription and over-the-counter medicines since 2007. Our headquarter is based in Sydney, NSW.
Through the support of our parent company, Alkem Laboratories Limited, we are focussed on a robust pipeline forecasted for the next decade. Pharmacor has proven success in launching first generics to market such as Cinacalcet, Rasagiline, Ezetimibe, Gliclazide and Paracetamol sustained release.
With global presence in over 50 countries, Alkem proudly operates 21 manufacturing facilities for both active material and finished products, and a passionate Research and Development team of over 500 scientists, in India and the United States. New ventures are presently being explored at Alkem’s subsidiaries, Enzene Biosciences, Maharashtra, and Norac Pharma, California, which offer biosimilars and controlled substance manufacturing, respectively.
Together, we are building a legacy in providing greater access to a wide range of therapeutic categories of medicine in Australia and around the world. Our mission at Pharmacor is ensuring Australians receive affordable, timely access to essential medicines without premium prices as Pharmacor proudly supplies over 100 medicines through PBS today, and will continue to grow in the future.
For more information about who we are, visit www.alkemlabs.com and www.pharmacor.com.au.
Gold Partner
Fresenius Medical Care is the world’s leading provider of products and services for people with chronic kidney failure. Around 3.7 million patients with this disease worldwide regularly undergo dialysis treatment.
We care for more than 346,000 patients in our global network of more than 4,000 dialysis clinics and operate 44 production sites; to provide dialysis products such as dialysis machines, dialyzers and related disposables.
The company’s strategy is geared toward sustainable growth. We aim to continuously improve patients’ quality of life by offering innovative products with varied treatment concepts, creating a future worth living.
Silver Partner
bioMérieux is a multi-national diagnostic company that has been a leader in the world of in-vitro diagnostics for >50 years.
We develop tests that bring high medical value for clinical decisions in the areas of infectious diseases, cardiovascular emergencies, targeted cancers and Womens’ Health and have recently added NEPHROCHECK® to help identify patients at risk of developing Acute Kidney Injury to our portfolio.
Our company is determined to continue to play a pioneering role by innovating and designing the diagnostics of the future to address the major challenges for public health worldwide.